Galen Robotics CTO, Dave Saunders, listed as one of 24 Medtech Voices to Follow in 2024 https://lnkd.in/eyppqa8K #AI #MEDTECH #SURGICALROBOTICS
About us
Galen Robotics is developing a single-platform solution to aid surgeons across several disciplines with minimal disturbance to existing workflows. Our cooperative control paradigm aims to eliminate hand tremor and enable surgeons to realize precise minimally invasive interventions in otolaryngology, head and neck surgery, and tissue reconstruction that were previously considered beyond human capacity.
- Website
-
http://www.galenrobotics.com
External link for Galen Robotics
- Industry
- Medical Device
- Company size
- 11-50 employees
- Headquarters
- Baltimore, Maryland
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Surgical Robotics and Micro-Surgical Robotics
Locations
-
Primary
Get directions
101 W Dickman St
Baltimore, Maryland 21230, US
-
Get directions
541 Jefferson Ave
Redwood City, California, US
-
Get directions
3400 N Charles St
Baltimore, Maryland, US
Employees at Galen Robotics
Updates
-
Enterprising Chief Officer & Product Evangelist | MDDI's Voice to Follow in 2024 | IP Portfolio Leadership l Excellence In Innovation & Commercialization l M&A/IPO/Startups l Board & Investor Advisor Delivering ROI
What have you learned about leading remotely that you can share? ✏️ I learned that needing to be in the office to do "real work" is a myth. Leading the development of a new surgical robot during the COVID lockdown, in a pre-revenue startup, was a brutal situation. At first I thought we were in big trouble, but we focused on operating using cloud-based tools like Arena, Jira, Jama, Slack, and Confluence. When the "wrench turners" needed to go into the office, we had a clearly documented on-site policy and everyone else focused on working as a team and continuing forward. Every week I shared our main goal over Zoom, and we broke that down into results the teams achieved towards that aim. At times I felt like a literal cheerleader, shouting out the same goal week after week, but we kept moving forward and eventually gained a de novo from the FDA for the first surgical robot of its kind. Making sure your goals are clear and having regular "visible" engagement from the entire team is critical to success in any situation, but even more so when people are working remotely. We even had a Slack channel called #Coffee-Break for Video Huddles for literal coffee breaks, posting memes and jokes. That may have been more instrumental to a solid remote work environment than anything else. #Remote #Office #Results #RemoteWork #Leadership #Innovation #HealthTech #Teamwork #DigitalTransformation #StartupLife #ProductDevelopment #FDAApproval #AgileMethodology #ProjectManagement #SurgicalRobotics #CloudComputing #Collaboration #EngineeringExcellence #VirtualTeam #TechLeadership #WorkflowOptimization #Covid19Response #StartupChallenges
-
Galen Robotics, Inc. Secures De Novo Grant for Galen ES, World's First Cooperatively Powered Robotic Surgical Assistant Platform for Ear, Nose, and Throat (ENT) Surgery #medtech #surgicalrobot #denovo #FDA https://lnkd.in/einZc56D
Galen Robotics, Inc. Secures De Novo Grant for Galen ES, World's First Cooperatively Powered Robotic Surgical Assistant Platform for Ear, Nose, and Throat (ENT) Surgery
prnewswire.com
-
Galen Robotics, Inc. Announces Bridge Round Into Series B Financing with Discounted Pricing Offer for Qualified Investors #medtech #financing #investors #surgicalRobotics
Galen Robotics, Inc. Launches Bridge Funding Round Following FDA Approval
Galen Robotics on LinkedIn
-
Interconnecting QMS and Product Risk Management in MedTech: Enhancing Safety and Reliability A Quality Management System (QMS) and the overall product risk management process in the MedTech sector are closely interconnected. The QMS provides the framework and systematic approach for managing product quality, while product risk management focuses on identifying, assessing, and mitigating risks associated with the MedTech product throughout its lifecycle. The relationship between a QMS and product risk management can be summarized as follows: Integration: A QMS should include risk management as an integral component, ensuring that risk assessment and mitigation activities are conducted in a structured and consistent manner throughout the product lifecycle. By integrating risk management into the QMS, MedTech companies can create a cohesive approach to identify and address potential risks impacting medical devices. Risk control measures: The QMS helps in establishing and implementing risk control measures to mitigate identified risks. These measures may include design changes, process improvements, ensuring adequate training for personnel, implementing safeguards, or enhancing quality control procedures. The QMS ensures that the effectiveness of these measures is monitored and continuously evaluated. Documentation and traceability: The QMS ensures that risk management activities are documented and traceable. This includes documenting risk assessments, risk control measures, risk mitigation plans, and effectiveness verification activities. The QMS also ensures that any changes implemented as a result of risk management activities are properly documented and controlled. Post-market surveillance: A QMS enables the collection and analysis of post-market surveillance data and feedback from customers, which can be valuable for identifying potential risks or safety concerns associated with the MedTech product. This feedback can then be analyzed via the risk management process to ensure ongoing product safety and performance. In summary, the QMS serves as the framework that the risk management activities are integrated into, in order to have a comprehensive quality management process in the MedTech industry. By integrating these two processes, MedTech companies can proactively identify, assess, and mitigate risks, ensuring the safety, reliability, and effectiveness of their products throughout their lifecycle. Originally published at: https://lnkd.in/eG6iNruC